Cargando…
PCR-based zebrafish model for personalised medicine in head and neck cancer
BACKGROUND: Currently, in vivo model for personalised cancer drug testing is challenging. A zebrafish larvae xenograft model has been applied in recent years to cancer research, particularly for drug testing purposes, showing promising results in drug testing against patient-derived tumour xenograft...
Autores principales: | Al-Samadi, Ahmed, Tuomainen, Katja, Kivimäki, Anne, Salem, Abdelhakim, Al-Kubati, Sakhr, Hyytiäinen, Aini, Parikka, Mataleena, Mesimäki, Karri, Wilkman, Tommy, Mäkitie, Antti, Grenman, Reidar, Salo, Tuula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647158/ https://www.ncbi.nlm.nih.gov/pubmed/31331338 http://dx.doi.org/10.1186/s12967-019-1985-1 |
Ejemplares similares
-
Crosstalk between tongue carcinoma cells, extracellular vesicles, and immune cells in in vitro and in vivo models
por: Al-Samadi, Ahmed, et al.
Publicado: (2017) -
The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testing
por: Hyytiäinen, Aini, et al.
Publicado: (2023) -
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma
por: Tuomainen, Katja, et al.
Publicado: (2021) -
Interleukin-17F Has Anti-Tumor Effects in Oral Tongue Cancer
por: Almahmoudi, Rabeia, et al.
Publicado: (2019) -
Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
por: Hyytiäinen, Aini, et al.
Publicado: (2021)